Catalyst
Slingshot members are tracking this event:
IPI-549 Updated Phase 1 Data From Monotherapy Dose Escalation Expected on April 4 at the American Association for Cancer Research (AACR) Annual Meeting 2017 taking place in Washington, D.C.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| INFI | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 01, 2017
Occurred Source:
http://www.prnewswire.com/news-releases/updated-phase-1-data-for-ipi-549-presented-at-aacr-annual-meeting-2017-300432992.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Ipi-549, Monotherapy Dose Escalation
